Back to top
more

OptimizeRx (OPRX)

(Delayed Data from NSDQ)

$12.53 USD

12.53
276,532

-0.33 (-2.57%)

Updated Aug 5, 2025 04:00 PM ET

After-Market: $12.54 +0.01 (0.08%) 6:42 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value A Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (93 out of 246)

Industry: Computer - Software

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Sapiens (SPNS) Beats Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Sapiens (SPNS) delivered earnings and revenue surprises of 14.81% and 0.39%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Earnings Preview: OptimizeRx Corp. (OPRX) Q1 Earnings Expected to Decline

by Zacks Equity Research

OptimizeRx Corp. (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research

OptimizeRx Corp. (OPRX) delivered earnings and revenue surprises of 22.22% and 1.07%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

OptimizeRx Corp. (OPRX) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

OptimizeRx Corp. (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

OptimizeRx Corp. (OPRX) Misses Q3 Earnings Estimates

by Zacks Equity Research

OptimizeRx Corp. (OPRX) delivered earnings and revenue surprises of -30.77% and 8.78%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

OptimizeRx Corp. (OPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

OptimizeRx Corp. (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

OptimizeRx Corp. (OPRX) delivered earnings and revenue surprises of 42.86% and 10.31%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

OptimizeRx Corp. (OPRX) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

OptimizeRx Corp. (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

OptimizeRx Corp. (OPRX) Upgraded to Strong Buy: Here's Why

by Zacks Equity Research

OptimizeRx Corp. (OPRX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

OptimizeRx Corp. (OPRX) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

OptimizeRx Corp. (OPRX) delivered earnings and revenue surprises of 200.00% and 8.79%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

OptimizeRx Corp. (OPRX) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

OptimizeRx Corp. (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Company News for Mar 17, 2021

by Zacks Equity Research

Companies in the news are: JBL, CNF, OPRX, MRNA

Zacks Equity Research

OptimizeRx Corp. (OPRX) Soars 12%: Is Further Upside Left in the Stock?

by Zacks Equity Research

OptimizeRx Corp. (OPRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Equity Research

OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

OptimizeRx Corp. (OPRX) delivered earnings and revenue surprises of 6.67% and 2.53%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

OptimizeRx Corp. (OPRX) to Report Q4 Results: Wall Street Expects Earnings Growth

by Zacks Equity Research

OptimizeRx Corp. (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

OptimizeRx's (OPRX) Shares March Higher, Can It Continue?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor in OptimizeRx (OPRX).

Zacks Equity Research

OptimizeRx (OPRX) Looks Good: Stock Adds 9.5% in Session

by Zacks Equity Research

OptimizeRx (OPRX) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

Zacks Equity Research

OptimizeRx's Shares March Higher, Can It Continue?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor in OptimizeRx.

Zacks Equity Research

Zacks.com featured highlights include: Digital Turbine, Perion, Controladora Vuela, OptimizeRx and Eldorado Gold

by Zacks Equity Research

Zacks.com featured highlights include: Digital Turbine, Perion, Controladora Vuela, OptimizeRx and Eldorado Gold

Swarup Gupta headshot

5 Breakout Stocks for Explosive Returns

by Swarup Gupta

This method involved zeroing in on those stocks whose prices are varying within a narrow band.

Zacks Equity Research

Has OptimizeRx (OPRX) Outpaced Other Computer and Technology Stocks This Year?

by Zacks Equity Research

Is (OPRX) Outperforming Other Computer and Technology Stocks This Year?

Zacks Equity Research

OptimizeRx (OPRX) to Report Q2 Earnings: What's in Store?

by Zacks Equity Research

OptimizeRx's (OPRX) second-quarter 2019 results are likely to benefit from increased sales of core financial and brand messaging products.

Zacks Equity Research

OptimizeRx (OPRX) Gains As Market Dips: What You Should Know

by Zacks Equity Research

OptimizeRx (OPRX) closed the most recent trading day at $15.09, moving +0.8% from the previous trading session.

Zacks Equity Research

OptimizeRx (OPRX) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

OptimizeRx (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

OptimizeRx (OPRX) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

In the latest trading session, OptimizeRx (OPRX) closed at $15.11, marking a -0.66% move from the previous day.